Human milk and mucosal lacto- and galacto-N-biose synthesis by transgalactosylation and their prebiotic potential in Lactobacillus species by Bidart, Gonzalo N. et al.
APPLIED GENETICS AND MOLECULAR BIOTECHNOLOGY
Human milk and mucosal lacto- and galacto-N-biose synthesis
by transgalactosylation and their prebiotic potential
in Lactobacillus species
Gonzalo N. Bidart1 & Jesús Rodríguez-Díaz2 & Martina Palomino-Schätzlein3 &
Vicente Monedero1 & María J. Yebra1
Received: 28 April 2016 /Revised: 7 September 2016 /Accepted: 20 September 2016
# Springer-Verlag Berlin Heidelberg 2016
Abstract Lacto-N-biose (LNB) and galacto-N-biose (GNB)
are major building blocks of free oligosaccharides and glycan
moieties of glyco-complexes present in human milk and gas-
trointestinal mucosa. We have previously characterized the
phospho-β-galactosidase GnbG from Lactobacillus casei
BL23 that is involved in the metabolism of LNB and GNB.
GnbG has been used here in transglycosylation reactions, and
it showed the production of LNB and GNB with N-
acetylglucosamine and N-acetylgalactosamine as acceptors,
respectively. The reaction kinetics demonstrated that GnbG
can convert 69 ± 4 and 71 ± 1 % of o-nitrophenyl-β-D-
galactopyranoside into LNB and GNB, respectively. Those
reactions were performed in a semi-preparative scale, and
the synthesized disaccharides were purified. The maximum
yield obtained for LNB was 10.7 ± 0.2 g/l and for GNB was
10.8 ± 0.3 g/l. NMR spectroscopy confirmed the molecular
structures of both carbohydrates and the absence of reaction
byproducts, which also supports that GnbG is specific for
β1,3-glycosidic linkages. The purified sugars were subse-
quently tested for their potential prebiotic properties using
Lactobacillus species. The results showed that LNB and
GNB were fermented by the tested strains of L. casei,
Lactobacillus rhamnosus (except L. rhamnosus strain ATCC
53103), Lactobacillus zeae, Lactobacillus gasseri, and
Lactobacillus johnsonii. DNA hybridization experiments sug-
gested that the metabolism of those disaccharides in 9 out of
10 L. casei strains, all L. rhamnosus strains and all L. zeae
strains tested relies upon a phospho-β-galactosidase homolo-
gous to GnbG. The results presented here support the putative
role of human milk oligosaccharides for selective enrichment
of beneficial intestinal microbiota in breast-fed infants.
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Introduction
The biological role of the high amount of oligosaccharides
present at human milk (human milk oligosaccharides,
HMOs) is largely unknown (Bode 2012; Garrido et al. 2013;
Thurl et al. 2010). HMOs are not digested, and therefore, they
reach the infant colon (Engfer et al. 2000). In this environ-
ment, it has been suggested that those oligosaccharides are
metabolized by the resident microbiota, and that they can act
as prebiotic substrates. Lacto-N-biose I (LNB; Gal-β1–
3GlcNAc) is the main building block of type-1 HMOs, and
it has also been found as a free sugar in human milk (Balogh
et al. 2015). This disaccharide is fermented in vitro by all the
tested strains of Bifidobacterium bifidum, Bifidobacterium
longum subsp. infantis, B. longum subsp. longum, and
Bif idobac ter ium breve , and by some s t ra ins of
Bifidobacterium pseudocatenulatum, Bifidobacterium
animalis subsp. animalis and Bifidobacterium pseudolongum
(Xiao et al. 2010). Additionally, fermentation of LNB using
stool samples from infants showed a significantly promoted
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growth of B. bifidum (Satoh et al. 2013). Other important
disaccharide is galacto-N-biose (GNB; Gal-β1–3GalNAc),
which is commonly found in glyco-complexes at the human
mucosal surfaces, and it also constitutes the functional struc-
ture of the T-antigen (Liu and Newburg 2013; Moran et al.
2011; Roy and Baek 2002). Regarding the metabolism of
LNB and GNB by Bifidobacterium species, it has been shown
that B. bifidum cleaves lacto-N-tetraose (LNT) in the culture
supernatant by the action of a lacto-N-biosidase. The LNB
generated, as well as GNB, are transported inside the cells
and then metabolize by a phosphorylase enzyme (Wada
et al. 2008). By contrast, B. longum subsp. infantis transports
LNT inside the cells and hydrolyzes this tetrasaccharide into
galactose and lacto-N-triose by a specific β-1,3-galactosidase
(Yoshida et al. 2012).
In addition to Bibidobacterium, the other genus with many
recognized probiotic strains is Lactobacillus (Hill et al. 2014;
Turroni et al. 2014). Species of this group are common inhab-
itants of the human gastrointestinal tract, and they are already
found at early stages of life. Regarding this, strains of
Lactobacillus casei, Lactobacillus gasseri, and Lactobacillus
rhamnosus are frequently isolated from breast-fed infant feces
(Albesharat et al. 2011; Martin et al. 2007; Rubio et al. 2014).
Positive probiotic effects of Lactobacillus species have been
shown on immune system stimulation, atopic disease, and
several types of diarrhea in children among others (Ashraf
and Shah 2014; Kalliomaki et al. 2003; Pedone et al. 2000;
Rodriguez-Diaz and Monedero 2013; Szajewska et al. 2013).
We have previously demonstrated that fucosyl-N-
acetylglucosamine disaccharides, that form part of HMOs
and also part of glyco-complexes from the mucosa, were
fermented by strains of L. casei, L. rhamnosus, B. breve, and
B. pseudocatenulatum (Becerra et al. 2015), suggesting a po-
tential prebiotic effect for those carbohydrates. Additionally,
we have characterized in L. casei strain BL23 the gnb operon
(gnbREFGBCDA) that is involved in the transport and catab-
olism of LNB and GNB (Bidart et al. 2014). Both disaccha-
rides are transported and phosphorylated by a specific phos-
phoenolpyruvate: sugar phosphotransferase system, and then
they are hydrolyzed into galactose-6P and the corresponding
N-acetylhexosamine by the phospho-β-galactosidase encoded
by gnbG gene. These results and the above described metab-
olism of LNB and GNB by Bifidobacterium species support
the utilization of both disaccharides as potential prebiotics. To
completely determine the biological function of LNB and
GNB as prebiotics, further investigation is needed, and con-
sequently, synthesis of sufficient amounts of them would be
necessary. Chemical synthesis of LNB, GNB, and LNB-
containing oligosaccharides such as Lewis a and b blood
group antigens has long been performed. However, several
protection and de-protection stages of the carbonyl groups
are necessary in order to get the proper selectivity, and hence,
the chemical synthesis became a time-consuming and
expensive process (Lemieux and Driguez 1975;
Wilstermann and Magnusson 1995). As an alternative, the
use of enzymes to synthesize HMOs has the convenience of
catabolizing specific glycosidic bonds in one step and inde-
pendently of other carbonyl groups. LNB and GNB have been
previously synthetized by the transglycosylation activity ofβ-
galactosidases (Fujimoto et al. 1998; Vetere et al. 2000) and
by multi-enzymatic systems (Nishimoto and Kitaoka 2007b;
Nishimoto and Kitaoka 2009; Yu et al. 2010). In the present
work, we have utilized the phospho-β-galactosidase GnbG
from L. casei BL23 (Bidart et al. 2014) in transgalactosylation
r e a c t i o n s w i t h N - a c e t y l g l u c o s am i n e a n d N -
acetylgalactosamine as acceptors and showed that it very ef-
ficiently synthesized LNB and GNB, respectively. Afterward,
the reactions were performed in a semi-preparative scale and
the produced disaccharides were purified and analyzed for
their in vitro fermentation by Lactobacillus species.
Materials and methods
Transgalactosylation activity assay
GnbG phospho-β-galactosidase (GH35 family) was
expressed with a His-tag and purified as previously described
(Bidart et al. 2014). Transgalactosilation activity of GnbGwas
analyzed in a solution containing 100 mM Tris-HCl buffer,
pH 7.5, o-nitrophenyl β-D-galactopyranoside (oNP-gal)
40 mM (donor) and N-acetylglucosamine (GlcNAc)
200mMorN-acetylgalactosamine (GalNAc) 200mM (accep-
tors). After the addition of GnbG to 0.17 U/ml (one unit was
defined as the amount of enzyme able to release 1 μmol of
oNP in 1 min at 42 °C, pH 7.5 and with oNP-gal 5 mM), the
reactions were incubated at 42 °C and samples were with-
drawn at different times and immediately heated at 100 °C
for 3 min to stop the reaction.
Transgalactosylation reactions aimed at the purification of
the produced disaccharides were performed in the conditions
described above for 3 h, and they were heat-treated to stop the
reaction.
Analytical and semi-preparative HPLC analysis
The transgalactosylation reaction products were analyzed and
purified by HPLC (Jasco PU2080Plus system) using analyti-
cal and preparative Rezex RCM-Monosaccharide columns
(Phenomenex, Torrance, CA, USA), respectively, as described
previously (Becerra et al. 2015). Di- and monosaccharides
were confirmed by comparison of their retention times with
those of standards (LNB, GNB, galactose, GlcNAc, and
GalNAc). LNB and GNB were obtained from Carbosynth
Ltd. (Compton, Berkshire, UK).
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Nuclear magnetic resonance spectroscopy
Lyophilized samples were dissolved in 550 μl of deuterated
water and analyzed immediately. Nuclear magnetic resonance
(NMR) spectra were recorded at 27 °C using a Bruker Avance
II 600 MHz spectrometer equipped with a 5-mm TCI cryo-
probe. One-dimensional (1D) 1H spectra with presaturation
and a noesy mixing period for water suppression and im-
proved baseline were acquired with 256 transients. 1H- 13C
heteronuclear single quantum coherence (HSQC) experiments
were acquired with 200 transients over a spectral width of 3.5
(for 1H) and 30 ppm (for 13C) and 128 points in the indirect
dimension. Total correlation spectroscopy (TOCSY) experi-
ments were acquired with 32 transients over a spectral width
of 3.5 ppm in both dimensions and 128 points in the indirect
dimension. NMR spectra were processed using the program
Topspin3.2 (Bruker Biospin).
Microorganisms and culture media
The Lactobacillus strains used in this study are listed in
Table 1. They were routinely grown at 37 °C under static
conditions in MRS medium (Difco, Sparks, MD, USA). The
recombinant Escherichia coli strain PE159 that expresses the
phospho-β-galactosidase GnbG (Bidart et al. 2014) was
grown in Luria-Bertani (LB) medium (Pronadisa, Madrid,
Spain) with ampicillin (100 μg/ml) at 37 °C under vigorous
shaking. The corresponding solid media were prepared by
adding 1.8 % agar.
Culture of Lactobacillus strains with lacto-N-biose
and galacto-N-biose
The Lactobacillus strains were grown at 37 °C under static
conditions in MRS basal medium as previously described
(Becerra et al. 2015). Lacto-N-biose (LNB) and galacto-N-
biose (GNB) utilization was determined by measuring growth
in 96-well microtiter plates in a POLARstar Omega micro-
plate reader (BMG Labtech, Offenburg, Germany) at 37 °C
under static conditions. Each well contained 100 μl of basal
MRS plus 4 mM of purified LNB or GNB. At least three
independent replicates for each condition were obtained. The
carbohydrates utilization at the end of the fermentation was
analyzed by HPLC as described above in filtered culture
supernatants.
Southern blot analysis
Total DNA was isolated from Lactobacillus strains with
the REALPURE “SSS” genomic DNA extraction kit
(Durviz, Paterna, Spain). A gnbG digoxigenin-labelled
probe was obtained by PCR with oligonucleotides
LNB5Fow (5′-TCG ATC GAT CAT GAG TTT ATG-3′)
and LNB5Rev (5′-TGC CTC ATC GCT GGC TTG-3′)
and the PCR Digoxigenin-labeling Mix (Roche) using
Taq DNA polymerase and L. casei BL23 DNA as tem-
plate. Chromosomal DNA from the Lactobacillus strains
was digested with EcoRV and separated in a 0.8 % aga-
rose gel. The digested DNA was transferred to Hybond-
N+ membranes (GE Healthcare) as previously described
(Sambrook et al. 1989). The membranes were hybridized
Table 1 List of Lactobacillus strains used in this study
Species Straina Culture collectionb
Lactobacillus rhamnosus BL1 CECT 278
Lactobacillus rhamnosus BL2 CECT 276
Lactobacillus rhamnosus BL3 CECT 275
Lactobacillus plantarum BL8 CECT 748
Lactobacillus curvatus BL14 CECT 904
Lactobacillus acidophilus BL17 CECT 903
Lactobacillus casei BL23 CECT 5275
Lactobacillus casei BL28 64 H
Lactobacillus casei BL32 CECT 4040
Lactobacillus delbruckii subsp. bulgaricus BL33 CECT 4005
Lactobacillus pentosus BL35 CECT 4023
Lactobacillus casei BL82 CECT 277
Lactobacillus casei BL83 CECT 4043
Lactobacillus casei BL86 CECT 4045
Lactobacillus casei BL87 ATCC 11578
Lactobacillus casei BL91 CECT 4646
Lactobacillus casei BL93 61 BG
Lactobacillus casei BL94 ATCC 393
Lactobacillus zeae BL95 ATCC 15820
Lactobacillus salivarius BL158 CECT 4063
Lactobacillus johnsonii BL261 AD99
Lactobacillus plantarum BL166 NCIMB 8826
Lactobacillus zeae BL257 IFI-CA
Lactobacillus gasseri BL277 ATCC33323
Lactobacillus acidophilus BL280 CECT 4179
Lactobacillus johnsonii BL281 CECT 289
Lactobacillus johnsonii BL287 DSM 10533
Lactobacillus intestinalis BL288 DSM 6629
Lactobacillus rhamnosus BL327 CECT 288
Lactobacillus taiwanensis BL340 DSM 21041
Lactobacillus rhamnosus BL358 HN001
Lactobacillus rhamnosus BL377 ATCC 53103
a BL, Culture Collection from our laboratory
b CECT, Spanish Type Culture Collection; ATCC, American Type
Culture Collection; DSM, Deutsche Sammlung von Mikroorganismen;
NCIMB, National Collection of Industrial, Food and Marine Bacteria,
UK; L. casei strains 64 H y 61 BG are described in (Gasser and Mandel
1968); L. rhamnosus HN001, also known as DR20, is described in
(Prasad et al. 1998); L. zeae BL257 was isolated from biological aging
wine (Moreno-Arribas and Polo 2008). L. johnsonii BL261 was isolated
from rat intestinal content (Sarmiento-Rubiano et al. 2007)
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with gnbG, washed, and visualized with CDP-Star




of the phospho-β-galactosidase GnbG
The phospho-β-galactosidase GnbG from L. casei BL23 has
been previously characterized showing that this enzyme is able
to hydrolyze lacto-N-biose (LNB) and galacto-N-biose (GNB)
(Bidart et al. 2014). These substrate specificities conducted us
in this work to examine the feasibility of using GnbG to syn-
thesize those disaccharides. We tested the transgalactosylation
activity of the 6×(His)GnbG with N-acetyl-glucosamine
(GlcNAc) or N-acetyl-galactosamine (GalNAc) as acceptor
and o-nitrophenyl-β-D-galactopyranoside (o-NPG) as donor.
HPLC analyses suggested that oligosaccharides were being
synthesized in each transglycosylation reaction whose reten-
tion time coincided with that of LNB and GNB standards,
respectively (Fig. S1). To analyze the transglycosylation kinet-
ics of GnbG, a time course reaction was performed and the
synthesis of LNB and GNB with GlcNAc and GalNAc as
acceptor, respectively, were determined (Fig. 1). The maxi-
mum transient yields of 69 ± 4 % for LNB and 71 ± 1 % for
GNBwith respect to the added o-NPGwere obtained after 3 h,
respectively.
Preparative scale synthesis, purification
and characterization of lacto-N-biose and galacto-N-biose
The transglycosylation reactions described above for GnbG
were scaled from microliters to milliliters in the conditions
described in the material and methods section. Both reactions
using GlcNAc and GalNAc as acceptor, respectively, were
independently loaded in a semi-preparative scale ion-
exclusion chromatography and the fractions containing LNB
and GNB were collected (Fig. S1). The maximum yields ob-
tained of LNB and GNB were 10.7 ± 0.2 and 10.8 ± 0.3 g/l,
respectively. The purified LNB and GNB were characterized
by NMR spectroscopy and compared with the commercial
disaccharides. Analysis of the corresponding 1D 1H and the
2D 1H-13C HSQC spectra (Figs. 2 and 3) revealed identical 1H
and 13C chemical shift values for purified and commercial
LNB and GNB. In addition, the acquisition of 2D TOCSY
experiments (Fig. S2) showed exactly the same spin coupling
patterns for the synthetized compounds and the standard
samples, and it also showed the lack of any additional signals
in the spectra of the purified compounds. These results
demonstrated the absence of reaction byproducts in the puri-
fied samples and confirmed the glycosidic linkage specificity
for both disaccharides. This further indicates that the
phospho-β-galactosidase GnbG is specific for β1,3-linkages
production.
In vitro fermentation of lacto-N-biose and galacto-N-biose
by Lactobacillus strains
The utilization of LNB and GNB by Bifidobacterium species
has been previously reported (Nishimoto and Kitaoka 2007a;
Satoh et al. 2013; Xiao et al. 2010). However, the fermentation
of these disaccharides by Lactobacillus, a genus with also
many probiotics strains, has not been tested. Therefore, in
order to analyze the capacity of several species of this genus
(Table 1) to metabolize LNB and GNB, the growth pattern in
MRS basal medium supplemented with these disaccharides
synthesized here was determined. No growth was observed
in the presence of LNB and GNB for the tested strains of
Lactobacillus plantarum , Lactobacillus curvatus ,
Lactobacillus acidophilus, Lactobacillus delbruckii subsp.
Bulgaricus, Lactobacillus pentosus, Lactobacillus salivarius,
Lactobacillus intestinalis, and Lactobacillus taiwanensis (data
not shown). In contrast, utilization of LNB and GNB was
evidenced in strains of L. casei, L. rhamnosus, Lactobacillus
zeae, L. gasseri, and Lactobacillus johnsonii. All the tested
strains of L. casei were able to grow on LNB and GNB as
carbon source (Fig. 4), including strain BL23, whose capacity
to ferment both sugars has been recently demonstrated in our
lab and it was used here as a positive control (Bidart et al.
2014). Utilization of LNB and GNB was also evidenced in 5
out of 6 strains of L. rhamnosus (Fig. 5). No growth difference
was observed for L.rhamnosus strain BL377 (the widely
marketed L. rhamnosus GG strain) in the presence of these
disaccharides with respect to the culture control without car-
bohydrate source. Sugar content analysis of the culture super-
natants detected LNB and GNB, respectively, in the
Time (h)

















Fig. 1 Time-dependent synthesis of lacto-N-biose (close symbols) and
galacto-N-biose (open symbols) by transglycosylation catalyzed by the
phospho-β-galactosidase GnbG from Lactobacillus casei. Yield is
expressed as a percentage of the donor concentration (o-nitrophenyl-β-
D-galactopyranoside 40 mM)
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supernatants from strain BL377, while they were consumed
by the rest of the strains tested from L. casei and L. rhamnosus
species.
The L. zeae (strains BL95 and BL257), L. gasseri (strain
BL277), and L. johnsonii (strains BL261, BL281, and BL287)
tested here were also able to grow with LNB and GNB
(Fig. 6). Sugar content analysis of the culture supernatants of
these strains showed that LNB and GNB were consumed.
Curiously, L. gasseri and L. johnsonii species, which are phy-
logenetically close (Zhang et al. 2011), presented similar
growth patterns, showing an autolytic phenotype. The cell
lysis might be due to induction of the already characterized
prophages in L. gasseri (Baugher et al. 2014; Ismail et al.
2009) and L. johnsonii (Denou et al. 2008; Ventura et al.
Fig. 3 1H 1D and 2D heteronuclear single quantum coherence (HSQC) NMR spectra acquired at 600 MHz and 27 °C 1H- 13C of a purified galacto-N-
biose and b commercial galacto-N-biose
Fig. 2 1H 1D and 2D heteronuclear single quantum coherence (HSQC) NMR spectra acquired at 600 MHz and 27 °C 1H- 13C of a purified lacto-N-



























































































































































































2003). As occurs in the majority of the tested lactobacilli, the
L. johnsonii strains grew better in GNB than in LNB. In this
later sugar, the cells began exponential growth only after 20
(strain BL287) or 40 h (strains BL261 and BL281), suggesting
a low induction of the metabolic genes by LNB or the involve-
ment of different metabolic routes for LNB and GNB.
Presence of genes homologous to gnbG in Lactobacillus
strains
We have previously shown that the ability of L. casei strain
BL23 to grow in the presence of LNB and GNB is dependent
upon the activity of the phospho-β-galactosidase GnbG
encoded by gnbG gene (Bidart et al. 2014). To find out if
the above Lactobacillus strains that ferment LNB and GNB
also contain a homologous gnbG gene, Southern blot analysis
was performed (Fig. 7). The results demonstrated that the
L. casei strains (BL28, BL32, BL82, BL83, BL86, BL87,
BL91, and BL93), L. rhamnosus strains (BL1, BL2, BL3,
BL327, and BL358), and L. zeae strains (BL95 and BL257)
that grow with LNB and GNB as carbon sources presented
hybridization signals, suggesting that, in these strains, the
metabolism of those disaccharides also relies on a
phospho-β-galactosidase homologous to GnbG. The only ex-
ception would be L. rhamnosus strain BL377 that as men-
tioned below may carry a non-functional gnb operon.
L. casei strain BL94 (ATCC 393) (Fig. 4), L. gasseri, and
L. johnsonii species (Fig. 6) can be cultured in the presence
of LNB or GNB, but in agreement with the lack of gnbG
homologues in their genomes as described below, no hybrid-
ization bands were present (Fig. 7), indicating that the hydro-
lysis of these carbohydrates must depend on a different
glycosidase.
Discussion
Many studies suggest that HMOs play important roles in
infant health (Bode 2012); however, the low availability of
these oligosaccharides limits the research about their function-
ality and their eventual application. In the present work, we
have utilized the phospho-β-galactosidase GnbG from
L. casei BL23 (Bidart et al. 2014) in transgalactosylation re-
actions directed to synthesize LNB and GNB. These are major
building blocks of oligosaccharides present in human milk
and gastrointestinal mucosa. The transgalactosylation effi-
ciency of GnbG is remarkably high compared with the effi-
ciency of other glycosidases, which usually is moderately
ranged from 20 to 40 % (Schmaltz et al. 2011; Trincone
2015). Indeed, LNB and GNB have been previously
Fig. 4 Growth curves of Lactobacillus casei strains BL23, BL28, BL32,
BL82, BL83, BL86, BL87, BL91, BL93, and BL94 in MRS basal
medium without added carbon source (triangles), with lacto-N-biose
(squares), or galacto-N-biose (circles) as the only carbon source. Data

























































































































































Fig. 5 Growth curves of Lactobacillus rhamnosus strains BL1, BL2,
BL3, BL327, BL358, and BL377 in MRS basal medium without added
carbon source (triangles), with lacto-N-biose (squares) or galacto-N-
biose (circles) as the only carbon source. Data presented are mean
values based on at least three replicates. Error bars indicate standard
deviations
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synthesized in transglycosylation reactions with the β-
galactosidase BgaC from Bacillus circulans, but with low
yields (12.2 and 10.1 % for LNB and GNB, respectively)
(Fujimoto et al. 1998). Although both enzymes, GnbG and
BgaC, belong to the glycoside hydrolase family 35, they only
showed a 41 % sequence identity, which might explain the
strong difference in the transgalactosylation efficiency be-
tween both enzymes. LNB has also been produced by the
transglycosylation activity of a β-galactosidase isolated from
the plant pathogen Xanthomonas manihotis (Vetere et al.
2000). This enzyme was shown to produce LNB at a
maximum yield of 55 % after 20 h reaction. Therefore,
GnbG displayed the highest transglycosylation rate for the
synthesis of LNB and GNB reported to date. Both disaccha-
rides have also been synthesized using a mix of four (sucrose
phosphorylase, lacto-N-biose phosphorylase, UDP-hexose 1-
P, and UDP-glucose 4-epimerase) (Nishimoto and Kitaoka
2007b; Nishimoto and Kitaoka 2009) or two enzymes (galac-
tose-1P kinase and lacto-N-biose phosphorylase) (Yu et al.
2010) resulting in a high efficiency of synthesis.
Knowledge about the fermentation of LNB and GNB is
almost limited to Bifidobacterium species (Satoh et al. 2013;
BL95
Time (h)




















































































































Fig. 6 Growth curves of Lactobacillus zeae strains BL95 and BL257,
Lactobacillus gasseri strain BL277, and Lactobacillus johnsonii strains
BL261, BL281, and BL287 in MRS basal medium without added carbon
source (triangles), with lacto-N-biose (squares), or galacto-N-biose
(circles) as the only carbon source. Data presented are mean values
based on at least three replicates. Error bars indicate standard deviations
94   95   17  280  277  288   23   261   281  287  340 158  166   257  327  358  377
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Fig. 7 Southern blot analysis of the EcoRV-digested genomic DNA from
Lactobacillus rhamnosus strains (BL1, BL2, BL3, BL327, BL358,
BL377), Lactobacillus casei strains (BL23, BL28, BL32, BL82, BL83,
BL86, BL87, BL91, BL93, BL94), Lactobacillus zeae strains (BL95 and
BL257), Lactobacillus gasseri strain (BL277), and Lactobacillus
johnsonii strains (BL261, BL281 and BL287). A DNA fragment
corresponding to gnbG from Lactobacillus casei strain BL23 was used
as a probe. Genomic DNA from this strain was used as positive control.
The numbers on the left indicate the size in kb of the DNA fragments from
BL23 strain
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Xiao et al. 2010). Here, we have shown that all L. casei strains
and all but one L. rhamnosus strains tested were able to grow
in the presence of both disaccharides. These results are in
agreement with the fact that more than 80 % of the available
genomes of the L. casei/paracasei/rhamnosus group contain
the gnb gene cluster involved in the transport and catabolism
of both sugars (Bidart et al. 2014). L. rhamnosus strain BL377
has a complete gnb operon (GenBank genome accession num-
ber FM179322); however, it did not ferment LNB and GNB
(Fig. 5). An analysis of the gnb cluster in this strain showed an
extra open reading frame (ORF), encoding a putative protein
of 82 amino acids that overlaps with the 3′ end of the gnbG
gene. The transcription and/or translation of that ORF might
affect the proper transcription and/or translation of the down-
stream gnb genes, which would result in the impairment of
strain BL377 to transport and hydrolyze LNB and GNB. Two
strains of L. zeae, a species which is phylogenetically close to
the L. casei/paracasei/rhamnosus group (Vasquez et al.
2005), were also able to grow in the presence of LNB and
GNB (Fig. 6). Analysis of the available genome sequence of
L. zeae strain BL95 (GenBank accession number
BACQ00000000) showed the presence of a complete gnb
operon, encoding proteins which deduced amino acid se-
quences ranging from 86 to 93 % identity respect to the
L. casei BL23 gnb gene products (Bidart et al. 2014).
Contrarily, L. casei strain BL94 (ATCC 393) can be cultured
in the presence of LNB or GNB (Fig. 4) but lacks gnbG
homologues in its genome (GenBank accession number
AZCO00000000). Similarly, the L. gasseri and L. johnsonii
strains tested here were able to ferment both disaccharides, but
do not contain a gnb cluster. BLAST search using the amino
acid sequence of phospho-β-galactosidase GnbG from
L. casei BL23 (Bidart et al. 2014) against the translated ge-
nomes of L. gasseri BL277 (ATCC 33323) (Azcarate-Peril
et al. 2008) and L. johnsonii BL287 (DSM 10533) (Sun
et al. 2015) did not show relevant homology with any protein,
suggesting the absence of an enzyme homologous to GnbG in
those strains. This is in agreement with the DNA hybridization
analysis showed above. Therefore, the hydrolysis of both di-
saccharides must rely upon other glycosidases. Indeed, the
L. gasseri BL277 genome encodes 20 putative glycosidases
(Azcarate-Peril et al. 2008), including several phospho-β-
glycosidases (Honda et al. 2012; Nagaoka et al. 2008). As
well, the L. johnsonii BL287 genome also encodes more than
20 putative glycosidases (Sun et al. 2015). However, the spec-
ificity of these enzymes is not known. Growth patterns, ge-
nome inspection, and hybridization with the gnbG probe dem-
onstrated that LNB and GNB utilization is a widespread fea-
ture in L. casei/paracasei/rhamnosus/zeae. This is a group of
species linked to the gastrointestinal habitat for which genes
for the utilization of other important human milk and mucosal
oligosaccharides have been described (Rodriguez-Diaz et al.
2012), highlighting the role of the utilization of this substrates
in the development in this particular niche. Whether
L. gasseri, L. johnsonii, and the L. casei ATCC393 strain rely
on systems similar to the bifidobacteria for LNB and GNB
catabolism, or they express new glycosidases with LNB and
GNB specificities remains to be investigated.
In this work, we have shown that the phospho-β-
galactosidase GnbG isolated from L. casei BL23 can be used
in transglycosylation reactions directed to synthesize LNB
and GNB, which are important disaccharides present in hu-
man milk, either free or forming part of the structure of oligo-
saccharides and glycoproteins. The reactions were efficiently
scaled and the produced LNB and GNB easily purified. The
prebiotic potential of these carbohydrates for enhancement of
specific Bifidobacterium species, as shown previously, and
Lactobacillus species, as shown here, support the putative role
of human milk oligosaccharides for selective stimulation of
the growth of beneficial gastrointestinal microbiota in breast-
fed infants. Furthermore, GnbG might be used in
transglycosylation reactions to produce derivative com-
pounds, such as glycosides of LNB and GNB.
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